Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/sciences-humaines-et-sociales/pediatric-anxiety-disorders/descriptif_3785265
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3785265

Pediatric Anxiety Disorders

Langue : Anglais

Coordonnateurs : Compton Scott N., Villabo Marianne A., Kristensen Hanne

Couverture de l’ouvrage Pediatric Anxiety Disorders

Pediatric Anxiety Disorders provides a critical, updated and comprehensive overview of anxiety disorders in children and adolescents based on the current state of empirical research. The book provides specific clinical recommendations which integrate new knowledge from neuroscience and innovative delivery formats for interventions. This is the first reference to examine anxiety diagnoses in accordance with the latest edition of the DSM-5, including childhood onset disorders, such as Separation Anxiety Disorder, Selective Mutism, Specific Phobia, Social Anxiety Disorder, Panic Disorder, Agoraphobia and Generalized Anxiety Disorder. The book assists clinicians in critically appraising the certainty of the evidence-base and the strength of clinical recommendations.

Section I. Foundations 1. Introduction 2. What is anxiety? 3. The genetic basis of child and adolescent anxiety 4. Etiological factors: Basic neuroscience 5. Etiological factors: Temperament and personality 6. Etiological factors; environment

Section II. Disorders 7. Specific phobia 8. Separation Anxiety disorder 9. Panic disorder and agoraphobia 10. Social anxiety disorder: An update on diagnostics; epidemiology; etiology; assessment, treatment; unanswered questions, and future directions 11. Selective mutism 12. Pediatric generalized anxiety disorder 13. Comorbidity in anxiety disorders

Section III. Interventions 14. Assessment of pediatric anxiety 15. Cognitive-behavioral therapy 16. Third-wave cognitive-behavioral therapies for the treatment of anxiety among children and adolescents 17. Pharmacologic treatment of pediatric anxiety disorders 18. New deliveries and technology 19. Dissemination and implementation

Section IV. Special Issues 20. When children and adolescents don't go to school: Terminology, technology, and trends 21. Ethnic and cultural considerations 22. Anxiety in emerging adulthood: A developmentally informed treatment model 23. Back to the future: Tracing the footsteps of Mary Cover Jones – The treatment of children and adolescents with anxiety disorders

Psychologists, psychiatrists, social workers; Researchers studying youth anxiety disorders; Graduate students of applied psychology, psychiatry and allied professions

Scott N. Compton, PhD, is associate professor at Duke University Medical Center, Department of Psychiatry and Behavioral Sciences and associate professor of Psychology and Neuroscience, Duke University. He is director of the program for child and adolescent anxiety disorders. Dr. Compton is an active researcher, scholar, and clinician. He has conducted multiple landmark comparative treatment trials in pediatric populations, and specifically in pediatric anxiety disorders. His publications span a wide range of topics, such as the treatment of anxiety disorders in childhood, cognitive-behavioral therapy, assessment, research methods to name a few.
Marianne A. Villabø, PhD, is a researcher and clinical psychologist at Akershus University Hospital in Norway. She has received extensive training in assessment and cognitive-behavioral treatment of anxiety disorders in children and adolescents. Dr. Villabø has conducted multiple clinical trials in the area of pediatric anxiety disorders, both in Norway and USA. She currently holds leadership roles in several studies on interventions for pediatric anxiety disorder in Norway. In addition to her research and publications in the area of pediatric anxiety, she is an accomplished clinician and educator.
Hanne Kristensen, MD, PhD, is recently retired from her position as head of Clinical Research at the Centre for Child and Adolescent Mental Health, Eastern and Southern Norway, but is still affiliated with the Centre. She is a child and adolescent psychiatrist with more than 30 years of clinical experience. Her research interests have included developmental disorder/delay in childhood anxiety disorders in general and in social anxiety disorder and selective mutism in particular. Dr. Kristensen is one of the leading experts on selective mutism and social anxiety disorder in children. Her group was one of the first to establish an adjusted CBT protocol for children with SM and to show effect in a randomized controlled trial.<
  • Uses the latest edition of the Diagnostic and Statistical Manual of Mental Disorders, the DSM-5
  • Includes the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach in assessing guideline development
  • Focuses on advances in etiology, assessment and treatment
  • Presents new advances in our understanding of the brain behind fear and anxiety
  • Uses a stepped care approach to treatment

Date de parution :

Ouvrage de 570 p.

19x23.3 cm

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

122,46 €

Ajouter au panier

Thème de Pediatric Anxiety Disorders :

Mots-clés :

ADHD; ASD; Acceptance and commitment therapy (ACT); Accommodation; Activity; Adolescence; Adolescent; Adolescents; Agoraphobia; Amygdala; Antidepressant; Anxiety; Anxiety assessment; Anxiety disorders; Anxiety sensitivity; Anxiety treatment; Assessment; Behavioral and cognitive-behavioral therapy; Behavioral genetics; Behavioral inhibition; Big Five; Biopsychosocial; Brain development; CBT; Child; Child social anxiety; Childhood; Children; Children and adolescents; Cognitive behavioral therapy; Cognitive models; Comorbidity; Conditioning; Course; Culture; Development; Developmental; Developmentally normative fears; Diagnosis; Diagnostic issues; Dialectical behavior therapy (DBT); Digital technology; Dissemination; Emerging adulthood; Emotional processing; Environment; Epidemiology; Ethnic minority youth; Ethnicity; Etiological factors; Etiology; Evolutionary psychiatry; Exposure therapy; Fear; Functional connectivity; Generalized anxiety; Generalized anxiety disorder; Generalized anxiety disorder (GAD); Genomics; Group treatment; Implementation; Implementation models; Implementation science; Individual treatment; Internet-based treatment; Maintenance; Metacognitive therapy (MCT); Mindfulness-based interventions (MBIs); Molecular genetics; Negative emotionality; ODD; One session treatment; Panic disorder; Parenting; Pediatric anxiety; Pediatric anxiety disorders; Positive emotionality; Prefrontal cortex; Prevalence; Problematic Internet use; Quantitative genetics; Race; SUD; School refusal behavior; Selective mutism; Selective serotonin reuptake inhibitor (SSRI); Separation anxiety; Separation anxiety disorder; Separation anxiety disorder (SAD); Shyness; Sociability; Social phobia; Social phobia (SoP); Specific phobia; Technology-delivered treatment; Therapygenetics; Translational neuroscience; Treatment; Twin studies; Worry